Supplemental material
Open access
1,513
Views
4
CrossRef citations to date
0
Altmetric
Research Paper
Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells
Alisha T. Poolea Department of Chemistry, Brandon University, Brandon, CanadaView further author information
, Christopher A. Sitkoa Department of Chemistry, Brandon University, Brandon, CanadaView further author information
, Caitlin Lea Department of Chemistry, Brandon University, Brandon, CanadaView further author information
, Christian C. Nausb Department of Cellular and Physiological Sciences, University of British Columbia, Life Science Institute, Vancouver, CanadaView further author information
, Bryan M. Hilla Department of Chemistry, Brandon University, Brandon, CanadaView further author information
, Eric A. C. Bushnella Department of Chemistry, Brandon University, Brandon, CanadaCorrespondence[email protected]
View further author information
& View further author information
Vincent C. Chena Department of Chemistry, Brandon University, Brandon, CanadaCorrespondence[email protected]
View further author information
show allView further author information
Pages 672-681
|
Received 21 Nov 2019, Accepted 06 Jan 2020, Published online: 11 Mar 2020
Related Research Data
Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation.
Source:
Proceedings of the National Academy of Sciences
Design, Synthesis, and Characterization of Potent, Slow-binding Inhibitors That Are Selective for Gelatinases
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
CCN3 (NOV) Interacts with Connexin43 in C6 Glioma Cells POSSIBLE MECHANISM OF CONNEXIN-MEDIATED GROWTH SUPPRESSION
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Potent and Selective Mechanism-Based Inhibition of Gelatinases
Source:
American Chemical Society (ACS)
Characteristics of C6 glioma cells overexpressing a gap junction protein.
Source:
Springer Science and Business Media LLC
Structure of matrix metalloproteinase-3 with a platinum-based inhibitor.
Source:
Royal Society of Chemistry (RSC)
Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes: solution studies and stability constants. Towards a zinc-selective binding group
Source:
Springer Science and Business Media LLC
The 2007 WHO Classification of Tumours of the Central Nervous System
Source:
Springer Nature
Prognostic significance of MMP-7 expression in colorectal cancer: A meta-analysis
Source:
Elsevier BV
Synthesis of Chiral 2-(4-Phenoxyphenylsulfonylmethyl)thiiranes as Selective Gelatinase Inhibitors
Source:
American Chemical Society (ACS)
Ex vivo and in vivo diagnosis of C6 glioblastoma development by Raman spectroscopy coupled to a microprobe
Source:
Springer Science and Business Media LLC
Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts
Source:
Elsevier BV
TERT promoter mutations in primary and secondary glioblastomas.
Source:
Springer Science and Business Media LLC
Reduction in gap junction intercellular communication promotes glioma migration
Source:
Impact Journals, LLC
Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats.
Source:
Ovid Technologies (Wolters Kluwer Health)
The 2007 WHO Classification of Tumours of the Central Nervous System
Source:
Springer Nature
Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A.
Source:
American Chemical Society (ACS)
Glioma invasion in the central nervous system.
Source:
Oxford University Press (OUP)
Recurrence Pattern Analysis of Primary Glioblastoma.
Source:
Elsevier BV
Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas.
Source:
Springer Science and Business Media LLC
Malonyl α-mercaptoketones and α-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors
Source:
Elsevier BV
Protease degradomics: a new challenge for proteomics.
Source:
Springer Science and Business Media LLC
A phase II trial of marimastat in advanced pancreatic cancer.
Source:
Springer Science and Business Media LLC
Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.
Source:
Oxford University Press (OUP)
Design and therapeutic application of matrix metalloproteinase inhibitors.
Source:
American Chemical Society (ACS)
The extracellular matrix: A dynamic niche in cancer progression
Source:
eScholarship, University of California
Sulfonamide derivatives as multi-target agents for complex diseases
Source:
Elsevier BV
Common mechanisms linking connexin43 to neural progenitor cell migration and glioma invasion
Source:
Elsevier BV
Recent non-hydroxamate matrix metalloproteinase inhibitors
Source:
Informa Healthcare
Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Source:
Springer Science and Business Media LLC
A novel strategy for designing specific gelatinase A inhibitors: potential use to control tumor progression
Source:
Elsevier BV
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.